ILC Therapeutics Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$3.18M
- Investors
-
6
ILC Therapeutics General Information
Description
Developer of novel peptide therapeutics intended to find a cure against COVID-19, ARDS, Oncology, Psoriasis and Atopic Dermatitis. The company builds interferon medicines called hybrid interferons that take features of natural interferon subtypes and combine them into one new hybrid interferon molecule that is designed to deliver enhanced efficacy and improved safety over a range of high-value therapeutic areas, enabling healthcare professionals to improve patient outcomes and find a cure against diseases.
Contact Information
Website
www.ilctherapeutics.comCorporate Office
- 100 West George Street
- Glasgow G2 1PP
- Scotland, United Kingdom
Corporate Office
- 100 West George Street
- Glasgow G2 1PP
- Scotland, United Kingdom
ILC Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series A) | 28-Jun-2024 | $3.18M | Completed | Generating Revenue | ||
| 6. Later Stage VC | 06-Sep-2021 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 27-Nov-2020 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 15-Nov-2019 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 09-Jul-2018 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 14-Dec-2017 | $567K | $957K | Completed | Generating Revenue | |
| 1. Seed Round | 30-Jul-2015 | $390K | $390K | Completed | Startup |
ILC Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| A Ordinary | ||||||||
| A Ordinary | ||||||||
| A Ordinary | ||||||||
| A Ordinary | ||||||||
| A Ordinary | ||||||||
| A Ordinary | ||||||||
| A Ordinary | ||||||||
| A Ordinary | ||||||||
| A Ordinary | 27,213 | $1.271303 | $11.21 | $11.21 | 1x | $11.21 | 3.76% | |
| A Ordinary | 5,555 | $1.271303 | $2.29 | $2.29 | 1x | $2.29 | 0.77% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
ILC Therapeutics Patents
ILC Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202314249-D0 | Compositions and method for treating disease | Inactive | 18-Sep-2023 | ||
| ES-2981369-T3 | Composition and methods relating to the treatment of diseases | Active | 17-Feb-2021 | ||
| JP-2024507313-A | Compositions and methods related to the treatment of diseases | Pending | 17-Feb-2021 | ||
| AU-2022223363-A1 | Compositions and methods relating to the treatment of diseases | Inactive | 17-Feb-2021 | ||
| CA-3190362-A1 | Compositions and methods relating to the treatment of diseases | Pending | 17-Feb-2021 | A61K38/212 |
ILC Therapeutics Signals
ILC Therapeutics Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ILCT management | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| Medical Incubator Japan | Venture Capital | Minority | ||
| Pioneer Group | Venture Capital | Minority | ||
| Eos Advisory | Venture Capital | Minority |
ILC Therapeutics FAQs
-
When was ILC Therapeutics founded?
ILC Therapeutics was founded in 2012.
-
Where is ILC Therapeutics headquartered?
ILC Therapeutics is headquartered in Glasgow, United Kingdom.
-
What is the size of ILC Therapeutics?
ILC Therapeutics has 3 total employees.
-
What industry is ILC Therapeutics in?
ILC Therapeutics’s primary industry is Drug Discovery.
-
Is ILC Therapeutics a private or public company?
ILC Therapeutics is a Private company.
-
What is the current valuation of ILC Therapeutics?
The current valuation of ILC Therapeutics is .
-
What is ILC Therapeutics’s current revenue?
The current revenue for ILC Therapeutics is .
-
How much funding has ILC Therapeutics raised over time?
ILC Therapeutics has raised $13.1M.
-
Who are ILC Therapeutics’s investors?
ILCT management, , Medical Incubator Japan, Pioneer Group, and Eos Advisory are 5 of 6 investors who have invested in ILC Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process